Related Experiment Videos
Vitamin D3 in dermatology: a critical appraisal
1Hoffmann-La Roche, Basel, Switzerland.
Abstract:
Vitamin D3 and its active metabolites can be generated within the skin. Their physiological activities encompass the regulation of calcium homeostasis, protooncogene expression and the production of a number of intracellular and secretory molecules from cells in various organs, including keratinocytes, fibroblasts and leukocytes. The major outcome of these activities is a decreased cellular proliferation and the modulation of inflammation and immunity, suggesting that these agents might be effective in the treatment of psoriasis, ichthyosis and allergic dermatitis. Several open and double-blind studies have indeed demonstrated some efficacy in psoriasis, but healing is slow and often incomplete. Higher doses are more effective but increase the potential of calcium deposition in the vascular tree and particularly the kidneys. Clinical results in ichthyosis and allergic dermatitis are disappointing. For the future, therapeutically more effective analogues of vitamin D3 with no calcium liability need to be developed.
Insights
Vitamin D3 shows some efficacy for psoriasis treatment by regulating cell growth and immunity. However, higher doses risk calcium buildup, and results for other skin conditions are limited, necessitating safer analogues.
Area of Science:
- Dermatology
- Endocrinology
- Immunology
Background:
- Vitamin D3 and its metabolites are synthesized in the skin.
- These compounds regulate calcium homeostasis, cell proliferation, and immune responses.
- Key target cells include keratinocytes, fibroblasts, and leukocytes.
Purpose of the Study:
- To evaluate the therapeutic potential of Vitamin D3 and its metabolites in skin diseases.
- To assess the efficacy and limitations of Vitamin D3 in treating psoriasis, ichthyosis, and allergic dermatitis.
- To identify the need for developing safer Vitamin D3 analogues.
Main Methods:
- Review of open and double-blind studies on Vitamin D3 in dermatological conditions.
- Analysis of physiological activities including calcium regulation and immune modulation.
- Assessment of clinical outcomes and side effects, particularly calcium deposition.
Main Results:
- Vitamin D3 demonstrated some efficacy in psoriasis treatment, but healing was slow and incomplete.
- Higher doses of Vitamin D3 increased the risk of vascular and renal calcium deposition.
- Clinical results for ichthyosis and allergic dermatitis were disappointing.
Conclusions:
- Vitamin D3 has a role in managing certain skin conditions like psoriasis.
- The therapeutic window for Vitamin D3 is limited by potential toxicity and incomplete efficacy.
- Development of Vitamin D3 analogues with reduced calcium liability is crucial for future therapies.